Showing results (1361-1370 of 14,091) with videos related to

Sort By:
Pageof 1,410
Gynecologic Oncology|January 26, 2010
The association between metabolic abnormality and endometrial cancer: a large case-control study in ChinaYan Zhang, Zhiwei Liu, Xinchun Yu, et al.
Gynecologic Oncology|January 26, 2010
Pure dysgerminoma of the ovary 35 years on: a single institutional experienceDanielle Vicus, Mario E Beiner, Shany Klachook, et al.
Gynecologic Oncology|November 20, 2009
A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: a gynecologic oncology group studyThomas F Rocereto, William E Brady, Mark S Shahin, et al.
Gynecologic Oncology|November 26, 2009
Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: a New York Cancer Consortium StudyDennis Yi-Shin Kuo, Stephanie V Blank, Paul J Christos, et al.
Gynecologic Oncology|September 21, 2016
Patterns of recurrence and survival in neuroendocrine cervical cancerShane R Stecklein, Anuja Jhingran, Jennifer Burzawa, et al.
Gynecologic Oncology|May 6, 2017
Salvage chemotherapy for gestational trophoblastic neoplasia: Utility or futility?Kathleen G Essel, Amanda Bruegl, David M Gershenson, et al.
Gynecologic Oncology|May 6, 2017
SYD985, a novel duocarmycin-based HER2-targeting antibody-drug conjugate, shows promising antitumor activity in epithelial ovarian carcinoma with HER2/Neu expressionGulden Menderes, Elena Bonazzoli, Stefania Bellone, et al.
Gynecologic Oncology|January 29, 2010
Quality of care in advanced ovarian cancer: the importance of provider specialtyCheryl Mercado, David Zingmond, Beth Y Karlan, et al.
Gynecologic Oncology|August 23, 2016
Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2Bradley J Monk, Andrés Poveda, Ignace Vergote, et al.
Gynecologic Oncology|August 21, 2016
Trends in hospice discharge, documented inpatient palliative care services and inpatient mortality in ovarian carcinomaShitanshu Uppal, Laurel W Rice, Anurag Beniwal, et al.
Pageof 1,410